|
|
|
|
|
|
|
|
|
|
"......The trial will be conducted on 750 patients in a double blind placebo controlled study randomized 1:1 of CVac vs. Standard of Care (currently there is no approved maintenance therapy for ovarian cancer), across multiple sites in Europe, the US and Australia....."
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.